Compounds for the treatment of cancer and metabolic diseases.

Abstract

The present invention relates to novel compounds of formulas (I) and (III), to said compounds for use as a medicament, more specifically for the prevention or treatment of diseases mediated by PTPN2 and / or PTPN1 activity, and more specifically for the prevention or treatment of cancer or metabolic diseases. The present invention also relates to a method for the prevention or treatment of said diseases comprising the use of the novel compounds. The present invention further relates to pharmaceutical compositions or combination preparations of the novel compounds, as well as to said compositions or preparations for use as a medicament, more preferably for the prevention or treatment of diseases mediated by PTPN2 and / or PTPN1 activity, and more particularly for the prevention or treatment of cancer or metabolic diseases.The present invention also relates to processes for the preparation of said compounds.